Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-citrulline in Pediatric SCD VOC
NCT04852172Phase 2Terminated
- Sponsor
- Asklepion Pharmaceuticals
- Start
- Apr 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Turnobi in sickle cell disease (SCD), sponsored by Asklepion Pharmaceuticals. Started Apr 2021; status: terminated.
02
Drugs
Turnobi
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04852172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852172.